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Importance 
Spotted fevers, which are caused by Rickettsia spp. in the spotted fever group 
(SFG), have been recognized in people for more than a hundred years. The clinical 
signs are broadly similar in all of these diseases, but the course ranges from mild and 
self-limited to severe and life-threatening. For a long time, spotted fevers were 
thought to be caused by only a few organisms, including Rickettsia rickettsii (Rocky 
Mountain spotted fever) in the Americas, R. conorii (Mediterranean spotted fever) in 
the Mediterranean region and R. australis (Queensland tick typhus) in Australia. 
Many additional species have been recognized as human pathogens since the 1980s. 
These infections are easily misidentified with commonly used diagnostic tests. For 
example, some illnesses once attributed to R. rickettsii are caused by R. parkeri, a less 
virulent organism.  
Animals can be infected with SFG rickettsiae, and develop antibodies to these 
organisms. With the exception of Rocky Mountain spotted fever and possibly 
Mediterranean spotted fever in dogs, there is no strong evidence that these organisms 
are pathogenic in animals. It is nevertheless possible that illnesses have not been 
recognized, or have been attributed to another agent. Rocky Mountain spotted fever, 
which is a recognized illness among dogs in the North America, was only recently 
documented in dogs in South America. 
Etiology 
Spotted fevers are caused by Rickettsia spp., which are pleomorphic, obligate 
intracellular, Gram negative coccobacilli in the family Rickettsiaceae and order 
Rickettsiales of the α-Proteobacteria. The genus Rickettsia contains at least 25 
officially validated species and many incompletely characterized organisms.  
The spotted fever group of Rickettsia contains a number of human pathogens, 
most of which are transmitted by ticks. R. rickettsii causes Rocky Mountain spotted 
fever, named for the region of North America where it was first identified. This 
disease is also called Brazilian spotted fever in Brazil. R. conorii subsp. conorii is the 
agent of Mediterranean spotted fever, also known as boutonneuse fever. Other 
subspecies of R. conorii cause Israeli spotted fever (R. conorii subsp. israelensis), 
Astrakhan spotted fever (R. conorii subsp. caspia) and Indian tick typhus (R. conorii 
subsp. indica). An illness known as either TIBOLA (tick-borne lymphadenopathy) or 
DEBONEL (Dermacentor-borne necrosis erythema lymphadenopathy) can be caused 
by both R. slovaca and R. raoultii. Other named syndromes include African tick-bite 
fever (R. africae), Japanese (or Oriental) spotted fever (R. japonica), Queensland tick 
typhus (R. australis), Flinders Island spotted fever (R. honei), lymphangitis-associated 
rickettsiosis (R. sibirica subsp. mongolitimonae), Siberian or North Asian tick typhus 
(R. sibirica subsp. sibirica) and Far Eastern tick-borne rickettsiosis (R. 
heilongjiangensis). R parkeri rickettsiosis (sometimes known as Tidewater spotted 
fever or American boutonneuse fever) is a recently-recognized illness in the 
Americas. R. massiliae, R. helvetica, R. monacensis and R. aeschlimannii are also 
known pathogens, while Rickettsia species 364D, R. tamurae, Candidatus R. 
andeanae and Candidatus R. amblyommii have been implicated in human illness.  
Two pathogenic members of the SFG rickettsiae are transmitted by other 
arthropods. R. felis (formerly known as the ELB agent) causes a syndrome known as 
flea-borne spotted fever or cat flea typhus. R. akari, which is transmitted by mites, 
causes rickettsialpox. 
Some SFG rickettsiae have been identified only in arthropods, and are of 
unknown pathogenicity for people and domesticated animals. 
Geographic Distribution 
A few SFG rickettsiae seem to be cosmopolitan, while others have been found in 
only limited areas (Table 1). They are often focally distributed within an endemic 
region. The distribution of some organisms is poorly understood.  
The two best characterized diseases, Rocky Mountain spotted fever (RMSF) and 
Mediterranean spotted fever (MSF), are limited to the Western or Eastern hemisphere, 
respectively. Rocky Mountain spotted fever occurs in North, Central and South 
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America. In the U.S., more than 60% of the cases are 
reported in five states (North Carolina, Oklahoma, 
Arkansas, Tennessee, and Missouri), with another focus of 
infection recently identified in the Southwest (Arizona). R. 
parkeri, which causes an illness that can be confused with 
RMSF, has been linked to clinical cases in the southeastern 
U.S., but might be more widely distributed in North 
America. It has also been associated with human illness in 
Uruguay, and it was found in ticks in Peru, Uruguay, 
Argentina and Brazil. Seropositive dogs were recently 
detected in Brazil. Several other pathogenic SFG 
rickettsiae, some of which are still poorly characterized, 
also occur in the Americas. 
Mediterranean spotted fever is most common in the 
area surrounding the Mediterranean basin, including 
northern Africa, the Middle East and southern Europe. It 
can also be seen in northern and central Europe, in foci 
where its tick vector survives in dog kennels and houses. 
Clinical cases have been reported from other regions, such 
as Africa, but some cases are poorly documented and might 
be caused by other organisms. MSF usually occurs in small 
foci, and one area can be affected for years without 
spreading to nearby regions. Additional subspecies of R. 
conorii cause distinct illnesses in other regions, some of 
which overlap with the distribution of R. conorii subsp 
conorii. Other SFG rickettsiae also occur in Europe, Asia 
and Africa, including areas where Mediterranean spotted 
fever is found. 
 
Table 1: Reported distribution of SFG rickettsiae 
Organism (Disease) Distribution 
R. aeschlimannii  Southern Europe, Africa. Organism also found in ticks in Kazakhstan 
R. africae (African tick-bite fever) Africa and the eastern Caribbean 
R. akari (rickettsialpox) Organism is cosmopolitan, including North America, Europe, Asia, Mexico, Africa. 
Disease reported especially in urban areas of northeastern U.S., but also in Europe 
(Croatia, Ukraine and Turkey), Korea, other areas  
R. australis (Queensland tick typhus) Australia 
R. conorii subsp. conorii (Mediterranean spotted 
fever)  
Mediterranean; also foci in northern and central Europe; cases reported in sub-Saharan 
Africa 
R. conorii subsp. indica (Indian tick typhus) Indian subcontinent 
R. conorii subsp. caspia (Astrakhan spotted 
fever) 
Russia (especially the Astrakhan region on the Caspian Sea), Kazakhstan; one case in 
Chad. Organism also found in ticks in Kosovo. 
R. conorii subsp. israelensis (Israeli spotted 
fever) 
Middle East, Portugal. Organism also found in ticks in Italy (Sicily).  
R. felis (flea-borne spotted fever) Possibly worldwide  
R. heilongjiangensis (Far Eastern tick-borne 
rickettsiosis)  
Russian Far East. Organism also found in ticks in China, possibly associated with 
human disease. 
R. helvetica Europe, Japan, Thailand, Laos 
R. honei (Flinders Island spotted fever)  Australia; Nepal. Organism also found in ticks in Thailand, Sri Lanka, Italy, U.S. 
(Texas) 
R. japonica  (Japanese spotted fever) Japan and south Korea, possibly other nearby regions 
R. massiliae  Europe, Africa (emerging disease in the Mediterranean region). Organism also found 
in ticks in the U.S. and South America. 
R. monacensis Spain, Italy.  
R. parkeri  U.S., Uruguay. Organism also found in ticks in Argentina, Brazil, Uruguay. 
R. raoultii (TIBOLA/ DEBONEL) Europe, Russia. Organism also found in China.   
R. rickettsii (Rocky Mountain spotted fever) western Canada, continental U.S., Mexico, Panama, Argentina, Brazil, Bolivia, 
Colombia, Costa Rica  
R. sibirica subsp. mongolitimonae (lymphangitis-
associated rickettsiosis) 
Africa, Europe (France, Greece), China 
R. sibirica subsp. sibirica (Siberian tick typhus) Northern Asia, including parts of Russia. and China 
R. slovaca (TIBOLA/ DEBONEL) Europe, Russia. Organism also found in ticks in China. R. slovaca is associated with 
two tick species that are common from Europe to central Asia. 
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Transmission 
Tick-borne spotted fevers 
Ticks are the vectors for most SFG rickettsiae, and 
transmit them in saliva while feeding. Ticks must usually be 
attached for several hours before the bacteria are reactivated 
and pass to the vertebrate host. Transmission of R. rickettsii 
(Rocky Mountain spotted fever) by Dermacentor andersoni 
requires at least 4-6 hours attachment, although 10-24 hours 
is more usual. Rhipicephalus sanguineus (the dog tick) 
typically transmits R. conorii (Mediterranean spotted fever) 
after 20 hours. The minimum attachment time needed to 
reactivate some organisms is unknown. Transovarial and 
transstadial transmission has been demonstrated for some 
organisms (e.g., R. rickettsii in Dermacentor andersoni, D. 
variabilis, R. sanguineus, Amblyomma cajennense and A. 
aureolatum; and R. conorii in Rh. sanguineus). Other SFG 
rickettsiae are also thought to be transmitted by these 
routes. 
Some known and proposed tick vectors for SFG 
rickettsiae are listed in Table 2. The most important vectors 
can vary with the region. D. variabilis (the American dog 
tick) and D. andersoni (the Rocky Mountain wood tick) 
transmit Rocky Mountain spotted fever in most of the U.S. 
and Canada, but Rh. sanguineus is the major vector in a 
focus of infection in Arizona. Rh. sanguineus is also 
thought to be important in Mexico. Amblyomma cajennense 
(the Cayenne tick) usually transmits RMSF to people in 
Central and South America, while Am. aureolatum (the 
yellow dog tick) is a vector in some urban areas of Brazil. 
SFG rickettsiae can also be acquired by exposure to a 
crushed tick’s tissues, fluids or feces, entering the body 
through breaks in the skin. Blood transfusions can transmit 
these organisms between people. In the laboratory, 
infections may occur after contamination of the mucous 
membranes, or in puncture wounds or cuts. Growing SFG 
rickettsiae in culture is particularly hazardous. Aerosol 
transmission of R. rickettsii has been reported after 
laboratory accidents.  
Table 2: Some known vectors for tick-borne SFG rickettsiae 
Organism (Disease) Vectors 
R. aeschlimannii  Mainly Hyalomma marginatum; also Rhipicephalus appendiculatus, Haemaphysalis 
punctata, Ixodes spp.  
R. africae (African tick-bite fever) Amblyomma hebraeum, Am. variegatum, Am. lepidum, Rh. appendiculatus, Rh. 
decoloratus 
R. australis (Queensland tick typhus) Ixodes holocyclus, I. tasmani; also found in I. cornuatus  
R. conorii subsp. conorii (Mediterranean spotted 
fever)  
Mainly Rh. sanguineus, also reported in Ha. leachii, Ha. punctaleachi  
R. conorii subsp. indica (Indian tick typhus) Rh. sanguineus, Rh. microplus, Ha. leachii  
R. conorii subsp. caspia (Astrakhan spotted fever) Rh. pumilio, Rh. sanguineus  
R. conorii subsp. israelensis (Israeli spotted fever) Rh. sanguineus  
R. heilongjiangensis (Far Eastern tick-borne 
rickettsiosis)  
Ha. concinnae, Ha. japonica, Dermacentor silvarum  
R. helvetica I. ricinus in Europe; also in I. ovatus, I. persulcatus, I. monospinosus  
R. honei (Flinders Island spotted fever)  The reptile tick Bothriocroton hydrosauri is the principal vector; also in Am. 
cajennense, I. granulatus, Ha. novaeguineae  
R. japonica  (Japanese spotted fever) Ha. flava and Ha. hystericis are probably the main vectors for humans in Japan; also 
in D. taiwanensis, I. ovatus, Ha. longicornis 
R. massiliae  Thought to be Rhipicephalus spp. including Rh. sanguineus, Rh. turanicus, Rh. 
muhsamae, Rh. lunulatus, Rh. sulcatus 
R. monacensis I. ricinus 
R. parkeri  Am. maculatum; also found in Am. americanum, Am. triste and Am. nodosum 
R. raoultii (TIBOLA/ DEBONEL) Rh. pumilio, D. nttalli, D. marginatus, D. silvarum, D. reticulatus 
R. rickettsii (Rocky Mountain spotted fever) D. andersoni, D. variabilis in North America, Am. cajennense, Am. aureolatum in 
South America; Rh. sanguineus in Arizona, Mexico and South America; also found 
in Am. imitator 
R. sibirica subsp. mongolitimonae (lymphangitis-
associated rickettsiosis) 
Hy. asiaticum, Hy. truncatum 
R. sibirica subsp. sibirica (Siberian tick typhus Dermacentor spp. are probably the main vectors for humans (D. nuttalli, D. silvarum, 
D. marginatus, D. auratus, D. sinicus, D. pictus); also in other Ixodidae including 
Ha. concinna, Ha. yeni, Ha. wellingtoni and other species 
R. slovaca (TIBOLA/ DEBONEL) D. marginatus, D. reticulatus  
 
Spotted Fevers 
Last Updated: November 2012 © 2012 page 4 of 15 
Flea-borne and mite-borne spotted fevers 
Two SFG rickettsiae, R. felis and R akari, are 
transmitted by arthropods other than ticks. R. felis has 
mainly been found in the cat flea, Ctenocephalides felis, 
which is currently the only arthropod known to be a 
biological vector. Transovarial and transstadial transmission 
has been reported in this flea. R. felis can also infect other 
fleas including C. canis, C. orientis, Anomiopsyllus nudata, 
Archaeopsylla erinacei, Ctenophthalmus sp., Xenopsylla 
cheopis, X. brasilliensis, Ceratophyllus gallinae, 
Spilospsyllus cuniculi and Echidnophaga gallinacea. The 
means of transmission to humans is still uncertain. R. felis 
was found in flea salivary glands in one study but not 
others. It has also been detected in flea feces. C. felis is 
found occasionally in other arthropods such as ticks, 
chiggers and mites, but these species might only be 
mechanical carriers after a blood meal.  
R. akari is transmitted by the mite Liponyssoides 
sanguineus. This mite infests mice and other small rodents, 
but will bite humans, especially if its normal hosts are absent. 
Transovarial transmission of R. akari has been reported in L. 
sanguineus. R. akari has also been detected in ticks. 
Vertebrates as reservoirs for SFG rickettsiae 
The idea that ticks act as both vectors and reservoirs 
for most of the SFG rickettsiae was proposed in the 1960s, 
and was generally accepted after that time. This idea has 
recently been questioned, in part because some species of 
Rickettsia (though not all) have detrimental effects on their 
tick vectors. R. rickettsii and R. conorii can decrease the 
survival, reproductive success or molting success of 
experimentally infected ticks, and are found in a very small 
percentage of the tick population in nature. This suggests 
that new lines of ticks must be reinfected from vertebrate 
hosts, to maintain these infections. Another argument for 
the existence of vertebrate reservoirs is that the vectors are 
sometimes more widely distributed than the organisms they 
carry. For example, the tick vector for R. conorii subsp. 
conorii is found worldwide between 50ºN and 35ºS, but 
Mediterranean spotted fever occurs in only part of this 
region. Vertebrates might act as reservoirs (or additional 
reservoirs) for an organism, or be amplifying hosts to infect 
additional ticks. This aspect of spotted fevers is still poorly 
understood and often speculative. 
Disinfection 
Rickettsiae are obligate intracellular organisms, and do 
not survive for long periods outside their hosts. Species of 
Rickettsia (i.e., R. rickettsii and R. akari) are expected to be 
susceptible to 1% sodium hypochlorite, 70% ethanol, 2% 
glutaraldehyde, formaldehyde and phenol. In some cases, 
the efficacy of these disinfectants was extrapolated from 
their effects on other Gram negative bacteria. Ordinary 
household disinfectants including 70% isopropyl alcohol or 
2% tincture of iodine can be used to disinfect a tick bite. 
Rickettsiae can be destroyed by moist heat of 121° C 
for a minimum of 15 min, or dry heat of 160-170° C for an 
hour. R. akari is reported to be inactivated rapidly at 56°C. . 
Infections in Humans 
Incubation Period 
Reported incubation periods for SFG rickettsioses 
range from one to 28 days. The incubation period for Rocky 
Mountain spotted fever (R. rickettsii) is usually 2 to 14 days 
(with a mean of 7 days) in the U.S., but one case series in 
Brazil estimated it to be one to 21 days, with a median of 12 
days. Mediterranean spotted fever tends to becomes 
apparent in approximately 7 days, African tick bite fever in 
5–7 days and rickettsialpox in 12-15 days. Other reported 
incubation periods are 2-9 days for Flinders Island spotted 
fever and 2-10 days for R parkeri rickettsiosis and Japanese 
spotted fever.  
Clinical Signs 
The general pattern of illness caused by SFG rickettsiae 
is similar: the affected individual usually develops a febrile 
illness, often followed by a rash. The form of the rash (e.g., 
maculopapular or papulovesicular) varies between diseases. 
An eschar (classically a painless black crusted ulcer with 
surrounding erythema) occurs at the inoculation site in many, 
but not all, spotted fevers. Multiple eschars are common in 
diseases where the person is typically bitten by more than 
one infected vector. Eschars are usually absent in Rocky 
Mountain spotted fever (R. rickettsii) and cat flea associated 
rickettsiosis (R. felis). Some spotted fevers (e.g., African tick-
bite fever) are not life threatening and are usually mild, while 
others, such as Rocky Mountain spotted fever, are often 
severe. A variety of organ systems can be affected in 
complicated or severe cases. 
The pattern of the rash, eschars and constitutional signs 
can sometimes suggest a diagnosis. For example, a patient 
with a mild illness, multiple eschars and a history of travel 
to the Caribbean is more likely to have African spotted 
fever than Rocky Mountain spotted fever.  
Rocky Mountain spotted fever (R. rickettsii) 
Rocky Mountain spotted fever is a moderate to severe 
disease in most patients. The initial signs can include 
malaise, fever, chills, headache and myalgia. The fever is 
usually high and the headache severe. Gastrointestinal signs 
including nausea, anorexia, vomiting, diarrhea and 
abdominal pain (which may be severe) are common. Some 
patients develop edema, which can be generalized or 
limited to the face, periorbital region or extremities. Ocular 
lesions may include conjunctivitis, photophobia or 
petechiae, as well as ocular hemorrhages, optic disc edema 
or vascular occlusion in more severe cases. An eschar is not 
usually seen. 
A nonpruritic macular rash, usually seen first on the 
wrists, forearms, ankles or scrotum, can appear from the 
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2nd to 14th day. Most patients in the U.S., but only half in 
Brazil, have a rash. The rash tends to develop sooner in 
children than adults. It spreads rapidly, often involving the 
palms or soles as well as the trunk and extremities. The 
spots initially blanch when pressed, but later may develop 
characteristic petechiae. A petechial rash is considered to be 
a sign of progression to severe RMSF. In the later stages, 
the petechiae can coalesce to form ecchymoses and may be 
followed by necrotic or gangrenous changes.  
Other body systems are affected in some patients. 
Respiratory signs may range from coughing to pneumonia, 
pulmonary edema and acute respiratory distress. Jaundice 
can develop, and acute renal failure is possible in severely 
affected patients. Neurological signs, ranging from transient 
deafness or insomnia to tremors, ataxia, amnesia, paralysis, 
hallucinations or coma, can develop relatively soon after 
the onset of clinical signs. Encephalitis or meningitis has 
been reported in some cases. Hemorrhages are common, 
due to damage to the blood vessels. Some patients have 
visible hemorrhages, but bleeding can also occur in internal 
organs, such as the gastrointestinal tract. Coagulopathies 
and thromboses may cause impairments in circulation, 
which can sometimes result in gangrene. Various other 
complications such as mucosal ulcers, myocarditis (and 
cardiac arrhythmias), hypotension, shock and multi-organ 
failure are also possible. Severe illness with a rapidly 
deteriorating course can occur in patients with glucose-6-
phosphate dehydrogenase deficiency, a sex-linked genetic 
condition that affects approximately 12% of African-
American males in the U.S.  
Although convalescence is usually rapid with early 
treatment, untreated patients may die within 1 to 2 weeks, 
and more severe cases often require hospitalization. 
Without treatment, the case fatality rate can be as high as 
85% in some regions. Sequelae, particularly after severe 
disease, may include gangrene of the extremities and 
various neurological signs. Some, but not all, sequelae 
eventually resolve.  
Rickettsia parkeri rickettsiosis 
R. parkeri rickettsiosis seems to be a milder disease 
than Rocky Mountain spotted fever, although the symptoms 
are similar. A distinguishing feature is that eschars are seen 
in most cases of R. parkeri rickettsiosis. They are 
occasionally multiple. Fever, headache and myalgia are 
reported to be milder than in RMSF, and nausea, vomiting 
and other gastrointestinal signs were uncommon in one case 
series. A few patients had tender regional 
lymphadenopathy. Photophobia and neck stiffness have 
been reported, but seem to be infrequent. Most patients with 
R. parkeri rickettsiosis have a maculopapular, 
vesiculopapular or papulopustular rash, mainly on the trunk 
and extremities. In some cases, the palms or soles or face 
are also involved. A petechial rash is not characteristic, 
although a few scattered petechiae may occasionally be 
found around the eschar. Severe neurological signs were 
not seen in one case series, and no deaths have been 
reported in treated patients.  
Mediterranean spotted fever  
(R. conorii subsp conorii) 
Like other spotted fevers, Mediterranean spotted fever 
begins as a febrile illness with nonspecific flu-like signs. 
Other symptoms can include an inoculation eschar (most 
often single), and a generalized maculopapular or purpuric 
rash, which usually involves the palms and soles. While 
almost all patients have a rash, an eschar was found in 
20%–86% of patients in some early descriptions of MSF. 
Some eschars are atypical, resembling a furuncle or other 
skin lesion, and may be difficult to recognize. Regional 
lymphadenitis is not usually seen.  
Although most cases of MSF are mild, severe and fatal 
cases are also seen. Complications can include renal, 
neurological, respiratory and cardiac conditions, as well as 
anemia, thrombocytopenia, phlebitis and ocular signs. 
Sequelae may include neurological deficits. Complications 
are more common with delayed treatment, or in older 
patients and those with debilitating diseases or glucose-6-
phosphate dehydrogenase deficiency.  
Other R. conorii infections 
Astrakhan spotted fever (R. conorii subsp. caspia) and 
Indian tick typhus (R. conorii subsp. indica) are febrile 
illnesses, with eschar and rash, that resemble Mediterranean 
spotted fever. 
The symptoms of Israeli spotted fever (R. conorii subsp 
israelensis) are also similar to Mediterranean spotted fever, 
but some reports suggest this disease might be more severe. 
In one study, patients with Israeli spotted fever developed 
gastrointestinal signs (nausea, vomiting and diarrhea) more 
often than patients with MSF. In contrast, eschars are less 
common., and have been reported in 4% to 38% of patients. 
Japanese spotted fever (R. japonica) 
Although Japanese fever occurs in both children and 
adults, approximately 75% of the patients at one hospital 
were between 50 and 80 years of age. Many of these cases 
were severe. The fever was often high, and most patients 
had shaking chills, headache and an eschar. A rash began 
on the extremities and spread within in a few hours to all 
parts of the body including the palms and soles. The rash 
usually became petechial after a few days, and disappeared 
within 2 weeks. Reported complications included cardiac 
signs, neurological signs, disseminated intravascular 
coagulation (DIC) and multiple organ failure. 
Queensland tick typhus (R. australis) 
Queensland tick typhus resembles other illnesses 
caused by SFG rickettsiae. Rash occurs in most cases. It can 
be either maculopapular or vesicular, and may resemble 
chickenpox. An eschar may also be seen. Although most 
cases seem to be mild and most patients recover without 
complications, a few cases have been severe or fatal. 
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Reported complications included renal dysfunction, 
respiratory failure, multiorgan failure and necrosis of the 
skin and extremities. 
African tick bite fever (R. africae) 
African tick bite fever is relatively mild and self-
limited. In addition to nonspecific flu-like signs, more than 
90% of patients have one or more inoculation site eschars. 
Multiple eschars are common, and atypical eschars may be 
seen. Neck muscle myalgia and subjective neck stiffness, as 
well as regional lymphadenitis, are also frequent. Less than 
half of all patients develop a generalized maculopapular or 
vesicular rash. If it is present, the rash is usually most 
apparent near an eschar. Aphthous stomatitis (mouth 
blisters) or lymphangitis have also been reported. 
Complications are uncommon, but may include prolonged 
fever, reactive arthritis and cranial or peripheral 
neuropathy. Life-threatening illness and fatal cases have 
never been reported.  
Flinders Island spotted fever (R. honei) 
Flinders Island spotted fever was first characterized on 
Flinders Island, Australia. This syndrome was described as 
a febrile illness of sudden onset, often followed by a 
maculopapular rash (without vesicles) on the trunk and 
limbs. An eschar was detected in approximately half of 
these patients. Most people recovered in 1-6 weeks even 
without antibiotics. No deaths were seen, although a third 
of the patients were hospitalized. Some R. honei infections 
reported in other geographic regions have differed from this 
description. In Nepal, a patient infected with R. honei 
developed a severe febrile illness that included diarrhea, 
severe arthralgia, hepatosplenomegaly, a purpuric rash, 
neurological signs, hypotension, tachycardia and hypoxia. 
Three patients in Thailand had a petechial maculopapular 
rash, in addition to a febrile illness, and one patient 
developed encephalopathy.  
R. honei has been found in the blood of some 
chronically ill patients in Australia, but it is still uncertain 
whether it has any causative role.  
TIBOLA/DEBONEL (R. raoultii and R. slovaca) 
The constitutional signs in TIBOLA/DEBONEL are 
generally reported to be mild, and fever and rash are 
uncommon. The eschar often occurs on the scalp, and 
localized alopecia may be seen at the site. Regional 
lymphadenopathy is relatively common and can be painful. 
Deaths have not been reported. 
Lymphangitis-associated rickettsiosis (R. 
sibirica subsp. mongolitimonae) 
An unusual characteristic of R. sibirica subsp. 
mongolitimonae infections is the presence of enlarged 
regional lymph nodes and lymphangitis extending from the 
eschar(s) to the draining lymph node. Additional symptoms 
include fever and maculopapular rash. Multiple eschars are 
common.  
Rickettsialpox (R. akari) 
Rickettsialpox is a relatively mild, self-limited disease. 
A single eschar occurs in more than 70% of cases. A febrile 
illness, often with a stiff neck, develops a few days later. 
Some patients also have a cough, nausea, vomiting or 
lymphadenopathy. A maculopapular rash develops on the 
trunk and extremities. It usually progresses to vesicles or 
pustules, and can resemble chickenpox. Fatal cases have not 
been documented.  
Cat flea–associated rickettsiosis (R. felis) 
The syndrome caused by R. felis has not been 
completely characterized. In one case series, almost all 
patients had a fever, and most had a rash, which was usually 
maculopapular. Only a few patients had an eschar. Various 
nonspecific clinical signs (e.g., back pain and myalgia), as 
well as gastrointestinal signs and coughing, have also been 
reported. Most cases have been mild, but reported 
complications include pneumonia and neurological signs.  
Other spotted fevers 
The characteristics of some spotted fevers are poorly 
understood, as only a few cases have been described. Some 
organisms appear to cause classical spotted fever signs, 
while others have been linked to mild illnesses that may not 
include a rash. Occasionally, reports have implicated 
members of the SFG rickettsiae in diseases that do not 
resemble spotted fevers.  
Communicability 
SFG rickettsiae are not transmitted directly from 
person to person, with the exception of medical procedures 
such as blood transfusions.  
Caution should be used when handling blood and tissue 
specimens that may contain these organisms, as well as ticks, 
their feces and tissues. In the laboratory, infections have been 
reported after accidental inoculation, contamination of the 
mucous membranes or exposure to aerosols. 
Diagnostic Tests 
Spotted fevers are often diagnosed presumptively 
based on the symptoms and history, and treatment is begun 
before the diagnosis is confirmed with laboratory tests.  
Most clinical cases are confirmed by serology. A 
fourfold rise in titer between acute and convalescent 
samples is considered to be diagnostic. Some cases may 
also be diagnosed based on single high titers. 
Immunofluorescence and immunoperoxidase assays are the 
most specific tests, but dot blot immunoassays and enzyme-
linked immunosorbent assays (ELISAs) are also available. 
Some tests, such as ELISAs, are qualitative rather than 
quantitative, and cannot be used to demonstrate rising titers. 
The Weil-Felix test, based on cross-reactive antigens of 
Proteus vulgaris, is nonspecific and insensitive and has 
generally been abandoned where better tests are available. 
Antibodies to R. rickettsii do not usually appear until 6 to 
10 days after the first clinical signs. Seroconversion may 
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occur even later in some diseases such as African tick-bite 
fever, where diagnostic titers often develop more than 3 
weeks after the onset of clinical signs. Antibody titers may 
be low if antibiotics were given early. Some healthy people 
have antibodies to SFG rickettsiae. 
SFG rickettsiae cross-react extensively, and the 
causative organism cannot be identified with ordinary 
serological tests. Most commercial immunofluorescence 
assays are based on a very limited selection of antigens (for 
example, R rickettsii in the United States). These tests also 
detect antibodies to other SFG rickettsiae, and do not identify 
the organism to the species level. Tests that can distinguish 
antibodies to different Rickettsia species are usually available 
only at regional reference laboratories. They include 
comparisons of titers to different organisms, cross-absorption 
of sera and immunoblotting (Western blotting). 
Rickettsial antigens or nucleic acids can sometimes be 
found in tissues and blood. Polymerase chain reaction 
(PCR) assays permit definitive identification of rickettsial 
species. They can also recognize novel SFG rickettsiae. 
Nucleic acids can be found in skin biopsies, especially of 
the eschar. In RMSF (where eschars are uncommon), the 
biopsy is taken from the rash. SFG rickettsiae can 
sometimes be found in blood samples, but rickettsemia is 
usually brief, and the organisms are often present at low 
levels. Direct immunofluorescence or immunoperoxidase 
staining can detect antigens in skin biopsies from living 
patients, or in tissues at autopsy. However, the organisms 
can be focally distributed and are not always found. As 
with serology, antibody-based tests only recognize the 
organisms as SFG rickettsiae and do not identify them to 
the species level. 
Culture of the organism is usually reserved for unusual 
or severe cases, when there is a compelling reason to identify 
the species. This test is usually available only at reference 
laboratories. Culturing SFG rickettsiae is hazardous, and 
requires a biosafety level 3 laboratory. As obligate 
intracellular organisms, rickettsiae do not grow on ordinary 
bacterial media, and must be isolated in living cells. The 
centrifugation shell vial technique, using human embryonic 
lung fibroblasts, is often employed. Older techniques for 
isolation included animal inoculation into male guinea pigs 
and inoculation into embryonated eggs. The organisms can 
be found in the skin (especially the eschar) or other tissues, 
and sometimes in the blood (especially early in the course of 
disease). Samples must be received quickly at the laboratory 
for isolation to be successful.  
Treatment 
Spotted fevers are usually treated without waiting for 
laboratory confirmation. The illness is less likely to be 
severe or fatal if antibiotics are begun early, and the 
response to treatment can be quicker. Treatment is not 
always necessary for some spotted fevers (e.g. 
rickettsialpox), but antibiotics may be given to shorten the 
illness.  
Only a few antibiotics, such as tetracyclines, are 
effective against rickettsiae. Doxycycline is currently the 
drug of choice. Other drugs such as fluoroquinolones, 
chloramphenicol, josamycin or newer macrolides may 
also be used in some situations (e.g., people with allergies 
to tetracyclines). There is a risk of serious side effects 
with chloramphenicol. A recent study raised concerns 
about the effectiveness of fluoroquinolones in SFG 
rickettsioses, compared to doxycycline. Drug availability 
varies between countries.  
Prevention 
Avoidance of tick bites is the cornerstone of prevention 
for tick-borne rickettsioses. Protective shoes and clothing 
(e.g., long-sleeved shirts and trousers tucked into socks) 
should be used in tick habitats. Ticks may be more visible 
on light-colored apparel. Clothing can be treated with 
acaricides such as permethrin. Tick repellents such as 
DEET are also helpful, but they are only effective for a 
short period against ticks, and must be reapplied 
periodically. For example, most tick repellents last less than 
2 hours against Amblyomma spp. ticks. Clothing should be 
removed and decontaminated immediately after leaving a 
tick-infested environment. 
People who enter tick habitats should check frequently 
for ticks, and remove them as soon as possible, using fine-
tipped tweezers or gloved hands. If gloves are not available, 
the fingers can be shielded with a tissue or paper towel. 
Bare hands are not recommended, as there is a risk of 
exposure to the tick’s tissue fluids or feces. The tick should 
not be squeezed, crushed or punctured. The U.S. Centers 
for Disease Control and Prevention (CDC) warns that tick 
removal techniques such as the use of hot matches or 
petroleum jelly may stimulate the tick to release additional 
saliva, and could increase the risk of infection. Tick bites 
should be disinfected after removal of the tick, and the 
hands should be washed with soap and water. The CDC 
recommends freezing the tick in a plastic bag, for 
identification in case of illness.  
Ticks should be removed from pets, both to prevent 
dogs from becoming ill and to prevent ticks from entering 
the home. Some monthly flea preventatives for pets are also 
effective against ticks. Acaricides, biological controls and 
control of tick habitats can decrease the populations of tick 
vectors in a community. Dogs can act as sentinels for 
Rocky Mountain spotted fever in humans. 
Two SFG rickettsiae are not transmitted by ticks. The 
risk of flea-borne spotted fever can be reduced by flea 
control on pets. Rickettsialpox is transmitted by a mite that 
is normally a parasite of mice and other small rodents. This 
mite may survive in the environment for up to two months, 
and humans are more likely to be bitten when the normal 
hosts have been destroyed. Concurrent acaricide treatment 
of the environment can eliminate these mites when wild 
rodents are eradicated.  
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There is currently no indication that prophylactic 
antibiotics can prevent spotted fevers after a tick bite, and 
some experimental evidence and observational studies 
suggest it would be ineffective.  
Morbidity and Mortality 
The risk of infection varies with the abundance and 
location of host ticks in the environment, and with their 
tendency to feed on humans. Ticks such as Rhipicephalus 
sanguineus strongly prefer to feed on animals and rarely 
bite people. Human infections transmitted by such ticks 
(e.g., Mediterranean spotted fever) tend to be sporadic. 
Other ticks, such as Amblyomma spp., feed aggressively on 
most mammals. Diseases carried by these ticks, such as 
African spotted fever, can occur in clusters when groups of 
people (for instance, on a safari) enter tick-infested 
environments. The infection rate in ticks is also highly 
variable. For example, R. parkeri is found in 10-40% of its 
tick vectors, but R. conorii and R. rickettsii usually occur in 
less than 2%.  
The precise morbidity and mortality rates for spotted 
fevers can sometimes be difficult to determine. At one time, 
all spotted fevers in the Americas were identified as either 
Rocky Mountain spotted fever or rickettsialpox, and many 
of the diseases in Europe were thought to be Mediterranean 
spotted fever. Even today, most illnesses are diagnosed with 
serological tests that do not identify SFG rickettsiae to the 
species level. The inclusion of other organisms could result 
in a disease appearing to be either milder or more severe 
than it truly is. 
Rocky Mountain spotted fever (R. rickettsii) 
In the U.S., Rocky Mountain spotted fever usually 
occurs between April and October, coinciding with the tick 
season in affected areas. Most cases are sporadic, although 
clusters are occasionally seen. The number of confirmed 
and probable cases in the U.S. increased from an average of 
3.0 per million population in 2000–2003, to 6.8 per million 
in 2004–2007 and 8 per million in 2008. Some of this 
increase might be due to better awareness, or to the 
adoption of a new, less stringent, case definition in 
surveillance. Infections with other organisms have 
undoubtedly been included in the statistics for RMSF. To 
reflect this, the reporting category was changed to “Spotted 
Fever Rickettsioses (including RMSF)” in 2010.  
Before effective treatments were available, up to 63-
87% of the cases in some parts of the U.S. and 75-80% of 
the cases in Brazil were fatal. Mortality from this disease 
has decreased steadily in the U.S. With modern antibiotics 
and supportive care, it was estimated to be approximately 
3% (range 3-5%) between 1981 and 1998, and decreased to 
1.4% (range 0.7–2.9%) in 1997–2002. The reason for the 
further decrease to 1.4% is not known, although some 
authors speculate that it might be related to the accidental 
inclusion of other diseases under “Rocky Mountain spotted 
fever.” Geographical variations in disease severity have 
been reported, both within North America, and in 
comparisons between North and South America. In one 
region of Brazil, severe cases are common, and the average 
case fatality rate was 39% during 1995–2004. In contrast, 
the clinical course is milder, and the case fatality rate lower, 
in another part of Brazil. Geographical differences might be 
caused by the virulence of local strains of R. rickettsii, 
differences in treatment, or the distribution of other 
Rickettsia that can be confused with R. rickettsii. 
R. parkeri rickettsiosis 
R. parkeri rickettsiosis is not the only illness that may 
be confused with Rocky Mountain spotted fever in the U.S.; 
however, it is the best characterized. This disease appears to 
be milder than RMSF. Approximately 33% of patients with 
R. parkeri rickettsiosis are hospitalized, compared to 75% 
of patients with RMSF. Neurological signs are also less 
common. In one case series, untreated patients with R. 
parkeri rickettsiosis were only moderately ill after 7–10 
days of fever, and there were no deaths. In contrast, the 
illness usually becomes increasingly severe in untreated 
RMSF.  
Mediterranean spotted fever  
(R. conorii subsp. conorii) 
Mediterranean spotted fever usually occurs in the 
spring and summer. The prevalence of this disease is 
reported to be 50 cases per 100,000 inhabitants in the 
Mediterranean region. In some areas (e.g., Italy and 
Portugal), the reported incidence has increased recently. 
MSF is transmitted by the dog tick Rhipicephalus 
sanguineous, and the risk of illness is associated with dog 
contact as well as tick burdens in the environment.  
Most cases of MSF are mild. Before antibiotics were 
available, the case fatality rate was estimated to be 1-3%. 
However, severe illnesses (defined in a variety of ways) and 
deaths have been documented regularly in the literature 
since the 1980s. Complications are more common in older 
patients, those with other debilitating diseases, and cases 
with delayed treatment, but seem to be uncommon in 
children. In several case series, the rate of severe organ 
involvement ranged from less than 1% in children, to 5% in 
large French studies, to 15% to 20% in some reports from 
Algeria, Bulgaria and the Iberian Peninsula. Most studies 
have reported a case fatality rate between 0% and 3%, but 
studies from Portugal suggest it might be higher. In 
Portugal, the number of hospitalized MSF patients 
increased from 176 in 1994 to 446 in 2004. The overall case 
fatality rate in these hospitalized patients was 3-7%, but it 
was much higher at two hospitals. In one region, it peaked 
at 32% in 1997. A later study found that some of the 
patients in this area had Israeli spotted fever, rather than 
MSF. This study reported that the case fatality rate was 
13% among these patients in 1994–2006, when only 
culture- or PCR-confirmed R. conorii subsp. conorii cases 
were included. Other SFG rickettsiae can also cause 
illnesses that can be confused with MSF. 
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Israeli spotted fever  
(R. conorii subsp. israelensis ) 
Some studies suggest that R conorii subsp. israelensis 
might be more virulent than R. conorii subsp. conorii, 
although this is still uncertain. A study from Portugal 
reported a case fatality rate of 29% in hospitalized patients 
with culture or PCR-confirmed Israeli spotted fever, 
compared to 13% in patients with similarly confirmed 
Mediterranean spotted fever. 
Japanese spotted fever (R. japonica) 
More than 200 cases of Japanese spotted fever were 
reported between 1984 and 1998 in Japan. This disease has 
been described in both children and adults., but in one case 
series, 75% of the patients were between 50 and 80 years of 
age. Many of these cases were severe. 
African tick bite fever R. africae) 
African tick bite fever is fairly common among 
travelers returning from southern Africa or the eastern 
Caribbean. Studies among Norwegian travelers to Africa 
reported an incidence of 4-5%. The prevalence of this 
disease in Africa is poorly understood. Although cases are 
rarely documented in some countries, the incidence was 
estimated to be 60–80 cases per 100,000 patients in some 
areas of Zimbabwe. African tick bite fever is likely to be 
underdiagnosed in some parts of Africa, due to the mildness 
of the clinical signs and the limited availability of medical 
care and/or diagnostic testing. As of 2012, complications 
appear to be uncommon, and life-threatening illness has not 
been reported. 
Rickettsialpox 
Rickettsialpox is reported to be mild and self-limited, 
and fatalities have not been documented. Most cases of 
rickettsialpox were described between 1940 and 1950, with 
few published cases in the last 30 years. Cases tend to be 
more common in urban environments when wild rodents 
have been eradicated, and the mites seek other hosts. 
Other illnesses 
Most cases of Queensland tick typhus (R. australis) are 
mild, but severe disease and deaths are possible. R. felis 
infections are also thought to be mild. No deaths were 
reported among patients with Flinders Island spotted fever 
(R. honei) on Flinders Island, Australia, even without 
antibiotic treatment. However, a recent R. honei case 
reported from Nepal was severe. TIBOLA/ DEBONEL (R. 
slovaca and R. raoultii) is unusual for a spotted fever in 
being more common in the winter. No deaths have been 
attributed to this disease, which is generally reported to be 
mild. Little is known about some spotted fevers, as only a 
few cases have been described. 
 
 
 
Infections in Animals 
Species Affected 
Infections 
SFG rickettsiae seem to be capable of infecting many 
species of mammals. Antibodies to this group of organisms 
have been reported in dogs, cats, horses, donkeys, mules, 
cattle, sheep, goats, pigs, rabbits and wild animals including 
deer, small mammals, carnivores and rodents. A few studies 
have demonstrated reactivity to a specific organism. 
Antibodies to R. rickettsii and R. parkeri were reported in 
dogs, horses and opossums; antibodies to R. rickettsii, R. 
akari and R felis in cats; and antibodies to R. japonica in 
dogs and cats. Based on PCR and/or culture, organisms that 
have been detected in dogs include R. conorii subsp. 
conorii, R. conorii subsp, israelensis, R. felis, R. parkeri 
and R. rickettsii. R. rickettsii has also been found in wild 
rodents and some other small animals such as opossums 
(Didelphis spp.). Experimental infections with R. conorii, 
R. rickettsii, R. parkeri and R. africae have been established 
in domesticated mammals. Some species of birds were 
infected experimentally with R. rickettsii. 
Little is known about potential amplifying or reservoir 
hosts for SFG rickettsiae. Rodents are thought to be 
amplifying hosts for R. rickettsii. Opossums might also 
amplify this organism, based on experimental studies. 
Rabbits (or small rodents living in rabbit burrows) were 
suggested as possible reservoir hosts for R. conorii subsp 
conorii, based on fluctuations in the incidence of human 
MSF that coincided with changes in the wild rabbit 
population in France. Dogs have been proposed as possible 
amplifying hosts for C. felis. 
Clinical cases 
Rocky Mountain spotted fever occurs in dogs. Dogs 
might also be affected by Mediterranean spotted fever, but 
this is still uncertain. Other spotted fever agents have 
occasionally been implicated in illnesses, but there is no 
definitive evidence for their involvement. 
Incubation Period 
In dogs, the incubation period for Rocky Mountain 
spotted fever is 2 to 14 days.  
Clinical Signs 
Rocky Mountain spotted fever (R. rickettsii) 
Dogs infected with R. rickettsii may remain 
asymptomatic or become mildly to severely ill. The clinical 
signs are highly variable, and may initially be nonspecific. 
Fever, anorexia and depression are the most commonly 
reported signs. Dogs may also have lymphadenopathy, a 
mucopurulent oculonasal discharge, gastrointestinal signs 
(abdominal pain, diarrhea, vomiting), respiratory signs 
(coughing, dyspnea) and joint or muscle pain. Some dogs 
develop edema on the face (e.g., the ears or lips), penile 
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sheath or extremities. Ocular signs, which may include 
focal retinal hemorrhages, chorioretinal exudate or retinal 
detachment, have been reported in some dogs. 
Thrombocytopenia is common but typically mild, and 
anemia may be seen. Epistaxis, petechial or ecchymotic 
hemorrhages, melena or hematuria occur in less than a 
quarter of all cases, and are generally due to vasculitis 
rather than low platelet numbers. Petechiae and ecchymoses 
tend to be found mainly on the oral, ocular and genital 
mucous membranes. Increased permeability of the blood 
vessels can cause hypotension and shock. 
Neurological signs are relatively common in dogs with 
RMSF. They may follow or occur at the same time as the 
initial constitutional signs. Vestibular dysfunction is 
reported frequently, but other abnormalities including 
altered mental states, generalized or localized 
hyperesthesia, intention tremors of the head, ataxia, 
seizures, paraparesis or tetraparesis may be seen. Cardiac 
complications, renal failure, necrosis of the extremities and 
DIC have been reported in severe cases. The prognosis is 
usually good in treated dogs, although death is possible. 
Mortality can be higher in dogs with cardiovascular 
complications, active bleeding or neurological signs. 
Few cases of RMSF have been described among dogs 
in South America. Two recently described cases in Brazil 
were similar to clinical cases reported in North America. 
One dog had fever, anorexia, diarrhea and hematochezia, 
followed by neurological signs including ataxia and 
vestibular syndrome with spontaneous nystagmus. Signs in 
the second dog included fever, anorexia, lethargy and 
vomiting. Dogs that were experimentally inoculated with a 
Brazilian strain of R. rickettsii developed fever, lethargy, 
anorexia and conjunctivitis, but no hemorrhagic, locomotor 
or neurological signs.  
Mediterranean spotted fever  
(R. conorii subsp conorii) 
Although dogs can be infected with R. conorii, there is 
only limited evidence that they might become ill. Mild 
fever, anorexia and lethargy lasting 2–3 days, followed by 
spontaneous recovery, were associated with R. conorii 
infections in three Yorkshire terriers. Other case reports of 
potential MSF described fever, prostration, petechial rash 
and thrombocytopenia. Doxycycline resulted in rapid 
clinical improvement in some dogs. A study from Portugal 
reported that 68% of dogs with suspected tick-borne illness 
(e.g., fever, lymphadenopathy, gastrointestinal signs, 
thrombocytopenia and petechial rash) had antibodies to 
SFG rickettsiae, compared to 39% of healthy dogs. R. 
conorii subsp. conorii and R. conorii subsp. israelensis 
were detected in a few of these dogs by PCR, and some 
other tick-transmitted infections were ruled out. 
Experimentally infected dogs are often asymptomatic, but 
in one study, dogs infected with R. conorii subsp conorii 
developed mild fever, anorexia and lethargy. In this study, 
inoculation of dogs with R. conorii subsp. israelensis 
resulted in milder signs in fewer animals. 
Other spotted fevers 
One dog with clinical signs of fatigue, vomiting, and 
diarrhea had evidence of R. felis infection, by PCR. 
Whether the organism had a causative role is uncertain, and 
some other dogs infected with this organism have been 
asymptomatic. In Australia, R. felis DNA was detected in 
9% of the dogs in an animal shelter, but infection was not 
associated with clinical signs.  
In California, two dogs with signs of Rocky Mountain 
spotted fever had higher antibody titers to R. massiliae than 
R. rickettsii, R. rhipicephali, or 364D Rickettsia. PCR 
evidence for R. massiliae was found in many ticks on the 
property. Nucleic acids were not detected in the dogs. 
In Tasmania, Australia, 59% of cats and 57% of dogs 
had antibodies to SFG rickettsiae, but there was no 
correlation between the animals’ health and seropositivity. 
Similarly, a study from the U.S. found no statistically 
significant link between fever in cats, and antibodies to 
Rickettsia spp. Attempts to detect Rickettsia spp. DNA in 
these cats, using PCR, were unsuccessful.  
No clinical signs that could be attributed to the 
organism were seen in calves inoculated with R. parkeri, or 
goats inoculated with R. africae. Cattle inoculated with R. 
africae developed only regional lymphadenopathy and 
inoculation site reactions.  
Communicability 
SFG rickettsiae are not transmitted directly between 
animals, but some species have sufficient levels of 
rickettsemia to infect ticks or other vectors. Transmission 
might be possible in blood transfusions. 
Animals can carry infected ticks or fleas, and may 
bring these vectors into closer contact with humans.  
Diagnostic Tests 
In dogs, Rocky Mountain spotted fever is usually 
diagnosed retrospectively by serology. Indirect 
immunofluorescence is used most often, but ELISAs are 
also available. A fourfold rise in titer between acute and 
convalescent samples is diagnostic. A single high titer may 
also be suggestive; however, dogs can develop clinical 
signs before they become seropositive. Conversely, healthy 
dogs can have antibodies to SFG rickettsiae. Due to cross-
reactivity, most serological tests cannot distinguish 
antibodies to different species of SFG rickettsiae. Such 
discriminatory tests are usually available only at reference 
laboratories. They include comparisons of titers to different 
organisms, cross-absorption of sera and immunoblotting 
(Western blotting). 
Rickettsial antigens or nucleic acids may be found in 
tissues and blood. PCR permits definitive identification of 
rickettsial species. It can also recognize novel SFG 
rickettsiae. Direct immunofluorescence or immuno-
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peroxidase staining can detect antigens. However, 
organisms can be focally distributed and are not always 
found. As with serology, immunostaining only recognizes 
the organisms as SFG rickettsiae, and does not identify 
them to the species level. Tests to detect antigens and 
nucleic acids may be available only at specialized 
laboratories, such as university or reference laboratories. 
Isolation of SFG rickettsiae from tissues or blood is 
rarely done. Culture is available only at reference 
laboratories, as it is hazardous and requires biosafety level 3 
conditions. Rickettsia spp. are obligate intracellular 
organisms, and must be isolated in cell cultures (or by older 
methods such as inoculation into male guinea pigs or 
embryonated eggs). Samples must be received quickly at 
the laboratory, for culture to be successful.  
Treatment 
Only a limited number of antibiotics are effective 
against SFG rickettsiae. Tetracycline antibiotics, especially 
doxycycline, are the drugs of choice. Other antibiotics, such 
as chloramphenicol or fluoroquinolones can also be 
effective; however, chloramphenicol has health risks for 
people. A recent study in humans raised questions about the 
effectiveness of fluoroquinolones compared to doxycycline. 
Antibiotics are most effective given early in the disease. 
Supportive treatment may be needed for dehydration and 
other clinical signs. 
Prevention 
Topical acaricides can be used to prevent tick bites. In 
tick-infested habitats, the animal’s skin and hair coat should 
be checked frequently, and any ticks should be removed 
with fine tipped tweezers or gloved hands. If gloves or 
tweezers are not available, the fingers can be shielded with 
paper. Bare hands are not recommended, as there is a risk 
of exposure to the tick’s tissue fluids or feces. The tick 
should not be squeezed, crushed or punctured, as its fluids 
may contain rickettsiae. The CDC warns against tick 
removal techniques such as the use of hot matches or 
petroleum jelly, which may stimulate the tick to release 
additional saliva and could increase the risk of infection. 
Acaricides, biological controls and habitat control can 
decrease tick populations in the environment. 
Morbidity and Mortality 
Rocky Mountain spotted fever has been reported 
among dogs in both North and South America. Cases tend 
to be sporadic, and occur most often in animals less than 
three years old. Some dogs are infected asymptomatically, 
while others develop mild to severe illness. German 
shepherds might become sick more often than other breeds, 
and English Springer spaniels with phosphofructokinase 
deficiency are thought to develop more severe disease. 
Antibiotics usually result in prompt improvement in cases 
without neurological signs or serious organ dysfunction; 
more severe infections may be slow to respond, and the dog 
may be left with residual deficits. Case fatality rates vary, 
but are reported to be as high as 10%. Mortality can be 
higher in dogs with cardiovascular complications, active 
bleeding or neurological signs.  
Post Mortem Lesions      Click to view images 
Lesions reported in dogs include focal ischemic 
necrosis, thrombi and occlusions in blood vessels, and 
valvular endocarditis. Edema may be seen on the face, 
extremities or male genital organs. Pulmonary edema can 
also be found in some dogs. Ecchymoses and petechiae 
can occur in various organs including the brain, heart, 
testes and lymph nodes. Microscopically, vasculitis and 
perivascular inflammatory cell infiltrates may be seen in 
most body tissues.  
Internet Resources 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/rmsf/index.html 
International Veterinary Information Service (IVIS)  
http://www.ivis.org  
Public Health Agency of Canada, Pathogen Safety Data 
Sheets http://www.phac-aspc.gc.ca/lab-bio/res/psds-
ftss/index-eng.php  
The Merck Manual 
http://www.merckmanuals.com/professional/index.html  
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp  
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